OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Repurposing antidiabetic drugs for Alzheimer's disease: A review of preclinical and clinical evidence and overcoming challenges
Jacky Tran, Sneh Parekh, Julia Rockcole, et al.
Life Sciences (2024) Vol. 355, pp. 123001-123001
Closed Access | Times Cited: 7
Jacky Tran, Sneh Parekh, Julia Rockcole, et al.
Life Sciences (2024) Vol. 355, pp. 123001-123001
Closed Access | Times Cited: 7
Showing 7 citing articles:
Repurposing of dipeptidyl peptidase FDA-approved drugs in alzheimer’s disease using network pharmacology and in-silico approaches
Miah Roney, Md. Nazim Uddin, Azmat Ali Khan, et al.
Computational Biology and Chemistry (2025) Vol. 116, pp. 108378-108378
Closed Access
Miah Roney, Md. Nazim Uddin, Azmat Ali Khan, et al.
Computational Biology and Chemistry (2025) Vol. 116, pp. 108378-108378
Closed Access
Repurposing Drugs: A Promising Therapeutic Approach against Alzheimer’s Disease
Swagata Pattanaik, Aruna Ghose, Kakarla Pakeeraiah, et al.
Ageing Research Reviews (2025), pp. 102698-102698
Closed Access
Swagata Pattanaik, Aruna Ghose, Kakarla Pakeeraiah, et al.
Ageing Research Reviews (2025), pp. 102698-102698
Closed Access
Glucagon-like-peptide-1-Rezeptoragonisten: eine neue pharmakologische Behandlungsoption für psychiatrische Erkrankungen?
Hubertus Himmerich
Der Nervenarzt (2025)
Open Access
Hubertus Himmerich
Der Nervenarzt (2025)
Open Access
Alzheimer’s Disease, Obesity, and Type 2 Diabetes: Focus on Common Neuroglial Dysfunctions (Critical Review and New Data on Human Brain and Models)
A. Tolédano, Arantxa Rodrı́guez-Casado, María‐Isabel Álvarez, et al.
Brain Sciences (2024) Vol. 14, Iss. 11, pp. 1101-1101
Open Access | Times Cited: 3
A. Tolédano, Arantxa Rodrı́guez-Casado, María‐Isabel Álvarez, et al.
Brain Sciences (2024) Vol. 14, Iss. 11, pp. 1101-1101
Open Access | Times Cited: 3
Novel PPAR-γ agonists as potential neuroprotective agents against Alzheimer's disease: rational design, synthesis, in silico evaluation, PPAR-γ binding assay and transactivation and expression studies
Duraipandi Devi Priya, Umme Hani, Nazima Haider, et al.
RSC Advances (2024) Vol. 14, Iss. 45, pp. 33247-33266
Open Access | Times Cited: 1
Duraipandi Devi Priya, Umme Hani, Nazima Haider, et al.
RSC Advances (2024) Vol. 14, Iss. 45, pp. 33247-33266
Open Access | Times Cited: 1
Exploring the Therapeutic Potential of DPP4 Inhibitors in Alzheimer's Disease: Molecular Insight and Clinical Outcome
Albert Joseph Sulangi, Sarah E. Lyons, Ahmed Ms Abdou, et al.
Cureus (2024)
Open Access | Times Cited: 1
Albert Joseph Sulangi, Sarah E. Lyons, Ahmed Ms Abdou, et al.
Cureus (2024)
Open Access | Times Cited: 1
Exploring DPP IV inhibitors for Alzheimer’s disease: Bridging diabetes and neurodegeneration
Swagata Pattanaik, Shakti Ketan Prusty, Pratap Kumar Sahu
Brain Research (2024) Vol. 1848, pp. 149342-149342
Closed Access | Times Cited: 1
Swagata Pattanaik, Shakti Ketan Prusty, Pratap Kumar Sahu
Brain Research (2024) Vol. 1848, pp. 149342-149342
Closed Access | Times Cited: 1
Impact of diabetes on the progression of Alzheimer’s disease via trajectories of amyloid–tau–neurodegeneration (ATN) biomarkers
Eun Woo Kim, Keun You Kim, Eosu Kim
The journal of nutrition health & aging (2024) Vol. 29, Iss. 2, pp. 100444-100444
Open Access
Eun Woo Kim, Keun You Kim, Eosu Kim
The journal of nutrition health & aging (2024) Vol. 29, Iss. 2, pp. 100444-100444
Open Access
